It was preliminarily demonstrated that trimerized HA5-I53_dn5B nanoparticle vaccines have good immunogenicity and can induce a humoral immune response, which lays a foundation for the development of novel and efficient H5 subtype influenza vaccines. This evidence concerns the gene KRT35 and influenza.